Thyroxine stimulates transglutaminase activity in articular chondrocytes

Osteoarthritis and Cartilage

Volumn 11, Issue 6, 2003, Pages 463-470

  Rosenthal, Ann K ^a   Heinkel, D ^a   Gohr, C M ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

Articular cartilage; Calcium pyrophosphate dihydrate; Thyroid hormones; Transglutaminase

Indexed keywords

BLOOD CLOTTING FACTOR 8A; CALCIUM; CYCLOHEXIMIDE; LEVOTHYROXINE; LIOTHYRONINE; MESSENGER RNA; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN KINASE C INHIBITOR; PROTEINASE; THYROID HORMONE; THYROXINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; BONE MINERAL; BONE MINERALIZATION; CARTILAGE CELL; CELL MATURATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; EXTRACELLULAR MATRIX; GROWTH PLATE; HISTOPATHOLOGY; INCUBATION TIME; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN SECRETION; RADIOMETRY; SWINE; THYROID HORMONE SYNTHESIS;

EID: 0037668879     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1063-4584(03)00074-8     Document Type: Article

References (29)

1. Greenberg C, Birckbichler PJ, Rice RH. Transglutaminases: multifunctional cross-linking enzymes that stabilize tissues. FASEB J 1991;5:3071-7.
2. Johnson K, Hashimoto S, Lotz M, Pritzker K, Terkeltaub R. Interleukin-1 induces pro-mineralizing activity of cartilage tissue transglutaminase and factor XIIIa. Am J Pathol 2001;159:149-63.
3. Rosenthal AK, Derfus BA, Henry LA. Transglutaminase activity in aging articular chondrocytes and articular cartilage vesicles. Arthritis Rheum 1997;40: 966-70.
4. Rosenthal A, Masuda I, Gohr C, Derfus B, Le M. The transglutaminase, Factor XIIIA, is present in articular chondrocytes. Osteoarthritis Cartilage 2001;9:578-81.
5. Summey BJ, Graff R, Lai T, Greenberg C, Lee G. Tissue transglutaminase localization and activity regulation in the extracellular matrix of articular cartilage. J Orthop Res 2002;20:76-82.
6. Rosenthal A, Henry L. Enhanced CPPD crystal deposition by aging chondrocytes is dependent on transglutaminase activity. Arthritis Rheum 1998;S237.
7. Auld G, Ritchie H, Robbie L, Booth N. Thrombin upregulates tissue transglutaminase in endothelial cells. Arterioscler Thromb Vasc Biol 2001;21: 1689-94.
8. Muszbek L, Haramura G, Polgar J. Transformation of cellular factor XIII into an active zymogen transglutaminase in thrombin-stimulated platelets. Thromb Haemost 1995;73:702-5.
9. Masuda I, Ishikawa K, Usuku G. A histologic and immunohistochemical study of calcium pyrophosphate dihydrate crystal deposition disease. Clin Orthop 1991;263:272-87.
10. Derfus B, Rachow J, Mandel N, Boskey A, Buday M, Kushnaryov V, et al. Articular cartilage vesicles generate calcium pyrophosphate dihydrate-like crystals in vitro. Arthritis Rheum 1992;35:231-40.
11. Anderson H. Vesicles associated with calcification in the matrix of epiphyseal cartilage. J Cell Biol 1969; 41:59-72.
12. Alini M, Kofshy Y, Wu W, Pidoux I, Poole A. In serum-free culture, thyroid hormones can induce full expression of chondrocyte hypertrophy leading to matrix calcification. J Bone Miner Res 1996;11: 105-13.
13. Rosenthal AK, Henry LA. Thyroid hormones induce features of the hypertrophic phenotype and stimulate correlates of CPPD crystal formation in articular chondrocytes. J Rheumatol 1999;26:395-401.
14. Aeschlimann D, Wetterwald A, Fleisch H, Paulsson M. Expression of tissue transglutaminase in skeletal tissues correlates with events of terminal differentiation of chondrocytes. J Cell Biol 1993;120:1461-70.
15. Nurminskaya M, Linsenmayer T. Analysis of upregulated genes during chondrocyte hypertrophy. Ann NY Acad Sci 1996;785:309-10.
16. Aeschlimann D, Mosher D, Paulsson M. Tissue transglutaminase and Factor XIII in cartilage and bone remodeling. Semin Thromb Hemost 1996;22:437-43.
17. Le M, Gohr C, Rosenthal A. Transglutaminase participates in the incorporation of latent TGFβ into the extracellular matrix of aging articular chondrocytes. Connect Tissue Res 2001;42:245-53.
18. Mandel S, Berry M, Kieffer J, Harney J, Warne R, Larsen R. Cloning and in vitro expression of the human selenoprotein, type I iodothyronine deiodinase. J Clin Endocrinol Metab 1992;74: 1133-9.
19. Croteau W, Davey J, Galton V, St Germain D. Cloning of the mammalian type II iodothyronine deiodinase. A selenoprotein differentially expressed and regulated in human and rat brain and other tissues. J Clin Invest 1996;98:405-17.
20. Ichinose A, Hendrickson L, Fujikawa K, Davie E. Amino acid sequence of the A subunit of human factor XIII. Biochemistry 1986;25:6900-6.
21. Gentile V, Saydak M, Chiocca E, Akande N, Birckbichler P, Lee K, et al. Isolation and characterization of cDNA clones to mouse macrophage and human endothelial cell tissue transglutaminase. J Biol Chem 1991;266:478-83.
22. Segal J, Ingbar S. Evidence that an increase in cytoplasmic calcium is the initiating event in certain plasma membrane-mediated responses to 3,5,3′ triiodothyronine in rat thymocytes. Endocrinology 1989; 124:1949-55.
23. Lawrence W, Schoenl M, Davis P. Stimulation in vitro of rabbit erythrocyte cytosol phospholipid-dependent protein kinase activity. J Biol Chem 1989;264: 4766-8.
24. Birckbichler P, Orr G, Conway E, Patterson M Jr. Transglutaminase activity in normal and transformed cells. Cancer Res 1977;37:1340-4.
25. Muszbek L, Yee V, Hevessy Z. Blood coagulation factor XIII: structure and function. Thromb Res 1999; 94:271-305.
26. Incerpi S, Luly P, De Vito P, Farias R. Short-term effects of thyroid hormones on the Na/H antiport in L-6 myoblasts: high molecular specificity for 3,3′,5-triiodo-L-thyronine. Endocrinology 1999;140:683-9.
27. Fisher D. Physiologic variations in thyroid hormones: physiologic and pathophysiologic considerations. Clin Chem 1996;42:135-9.
28. Schussler G. The thyroxine-binding proteins. Thyroid 2000;10:141-9.
29. Berry D, Rose C, Remo B, Brown D. The expression pattern of thyroid hormone response genes in remodeling tadpole tissues defines distinct growth and resorption gene expression programs. Dev Biol 1998; 203:24-35.